Back to Results
First PageMeta Content
Ranibizumab / Macular edema / Macular degeneration / Bevacizumab / Central retinal vein occlusion / Laser coagulation / Retina / Macula of retina / Central retinal vein / Ophthalmology / Medicine / Vision


Document Date: 2014-10-01 21:56:22

Open Document

File Size: 48,68 KB

Share Result on Facebook

City

Trial / /

Company

Novartis Pharmaceuticals Australia Pty Ltd / AMD / Novartis Pharmaceuticals Pty Ltd / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

MedicalCondition

unilateral diseases / Macular Edema Due to Retinal Vein Occlusions / Branch Retinal Vein Occlusion / Central Retinal Vein Occlusion / Macular Oedema Following Branch Retinal Vein Occlusion / diseases / complete blindness / blood clot / disease / Proposed Therapy Retinal vein occlusion / retinal vein occlusion / thrombus / macular degeneration / /

MedicalTreatment

laser therapy / laser treatment / sham treatment / laser treatments / /

Organization

Drug Utilisation SubCommittee / Medical Services Advisory Committee / Listing Requested and PBAC’s View Authority / /

Person

Shamb Shamb / /

Position

Publication citation Trial ID/First Author / Trial ID/First Author / /

Product

BRAVO / Lucentis / RVO / FVF4165g / /

PublishedMedium

Ophthalmology / /

Technology

laser / tomography / /

SocialTag